Enrestec Statistics

Total Valuation

Enrestec has a market cap or net worth of TWD 5.12 billion. The enterprise value is 6.26 billion.

Market Cap	5.12B
Enterprise Value	6.26B

Important Dates

The last earnings date was Friday, April 18, 2025.

Earnings Date	Apr 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Enrestec has 102.10 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	102.10M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	33.49%
Owned by Institutions (%)	n/a
Float	43.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.93
PB Ratio	3.93
P/TBV Ratio	6.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 108.70, with an EV/FCF ratio of -49.37.

EV / Earnings	-916.41
EV / Sales	18.28
EV / EBITDA	108.70
EV / EBIT	n/a
EV / FCF	-49.37

Financial Position

The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.63.

Current Ratio	0.79
Quick Ratio	0.55
Debt / Equity	0.63
Debt / EBITDA	14.20
Debt / FCF	-6.45
Interest Coverage	-3.12

Financial Efficiency

Return on equity (ROE) is -4.95% and return on invested capital (ROIC) is -1.47%.

Return on Equity (ROE)	-4.95%
Return on Assets (ROA)	-1.39%
Return on Invested Capital (ROIC)	-1.47%
Return on Capital Employed (ROCE)	-2.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.15
Inventory Turnover	4.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.96% in the last 52 weeks. The beta is 0.01, so Enrestec's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	-1.96%
50-Day Moving Average	55.53
200-Day Moving Average	57.95
Relative Strength Index (RSI)	43.98
Average Volume (20 Days)	35,574

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enrestec had revenue of TWD 342.70 million and -6.84 million in losses. Loss per share was -0.07.

Revenue	342.70M
Gross Profit	62.68M
Operating Income	-49.22M
Pretax Income	-57.24M
Net Income	-6.84M
EBITDA	56.15M
EBIT	-49.22M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 116.07 million in cash and 818.62 million in debt, giving a net cash position of -702.55 million or -6.88 per share.

Cash & Cash Equivalents	116.07M
Total Debt	818.62M
Net Cash	-702.55M
Net Cash Per Share	-6.88
Equity (Book Value)	1.30B
Book Value Per Share	8.38
Working Capital	-69.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.73 million and capital expenditures -119.15 million, giving a free cash flow of -126.88 million.

Operating Cash Flow	-7.73M
Capital Expenditures	-119.15M
Free Cash Flow	-126.88M
FCF Per Share	-1.24

Full Cash Flow Statement

Margins

Gross margin is 18.29%, with operating and profit margins of -14.36% and -1.99%.

Gross Margin	18.29%
Operating Margin	-14.36%
Pretax Margin	-16.70%
Profit Margin	-1.99%
EBITDA Margin	16.38%
EBIT Margin	-14.36%
FCF Margin	n/a

Dividends & Yields

Enrestec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.13%
FCF Yield	-2.48%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Enrestec has an Altman Z-Score of 3.68.

Altman Z-Score	3.68
Piotroski F-Score	n/a